SEC Form 4 · accession 0001104659-17-019996
PRA Health Sciences, Inc. · PRAH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David W Dockhorn
Officer — Executive Vice President & CCO
Period of report
Mar 27, 2017
Accepted (ET)
Mar 29, 2017 · 4:03 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001613859
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 27, 2017 | M | 55,574 | $2.94 | A | 55,574 | D | |
| Common Stock | Mar 27, 2017 | S | 55,574 | $62.00 | D | 0 | D | |
| Common Stock | Mar 27, 2017 | M | 29,608 | $11.73 | A | 29,608 | D | |
| Common Stock | Mar 27, 2017 | S | 29,608 | $62.00 | D | 0 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F2 | $2.94 | Mar 27, 2017 | M | 55,574 | D | — | Dec 21, 2017 | Common Stock | 55,574 | 0 | D |
| Stock Option (Right to Buy)F3 | $11.73 | Mar 27, 2017 | M | 29,608 | D | — | Dec 20, 2023 | Common Stock | 29,608 | 55,665 | D |
Explanation of responses
- F1The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
- F2The options vested on September 23, 2013.
- F317,054 of the options vested on September 23, 2014; 12,554 of the options vested on September 23, 2015.